Metastatic breast cancer: AstraZeneca's Faslodex (fulvestrant) approved for new indic
AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved a new indication in the US, expanding the use of Faslodex® (fulvestrant) to include use in combination with...